Pharming Group N.V. PHARM.AS NL Equity
€1.01
+0.00 (+0.40%)
EUR · as of 2026-08-27 · marketstack
Pharming Group N.V. (Euronext Amsterdam: PHARM.AS) closed at €1.01, +0.4%, on 2026-08-27, with a return on equity of 1.1%, a net margin of 0.8% and 3-year sales growth of 22.3%. Institutional ownership, earnings history and filed financials are on the tabs below.
Short interest· FINRA consolidated · settlement 2026-08-14· PHARPharming Group N.V.
6 settlement cyclesShort interest shown for the US-listed sibling PHAR — FINRA covers US listings; figures are that line's shares.
| Shares short | 73K |
| % of shares out | — |
| Days to cover | 2.4 |
| Δ vs 2026-07-31 | +279.0% |
bars = shares short · line = days to cover (own scale)
% of shares outstanding suppressed: the listed line's share basis (ADR/depositary) differs from the reported ordinary share count.
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.